Cold agglutinin disease: current challenges and future prospects

Cold agglutinin disease (CAD) is a complement-dependent, classical pathway-mediated immune hemolytic disease, accounting for 15–25% of autoimmune hemolytic anemia, and at the same time, a distinct clonal B-cell lymphoproliferative disorder of the bone marrow. The disease burden is often high, but no...

Descripción completa

Detalles Bibliográficos
Autores principales: Berentsen, Sigbjørn, Röth, Alexander, Randen, Ulla, Jilma, Bernd, Tjønnfjord, Geir E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497508/
https://www.ncbi.nlm.nih.gov/pubmed/31114413
http://dx.doi.org/10.2147/JBM.S177621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497508/
https://www.ncbi.nlm.nih.gov/pubmed/31114413
http://dx.doi.org/10.2147/JBM.S177621

Ejemplares similares